Health Trials

PCSK9

1

Review clinical trials related to PCSK9. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

The primary objective was to evaluate the effect of PCSK9 inhibitors in addition to the background lipid-modifying therapy (LMT), compared with standard LMT in terms of clinical outcomes in patients with coronary CT angiography (CCTA)-detected high-risk plaques.

Participants needed: 3,596
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Feb 6, 2026Locations: 6
Eligibility criteria

Subject must be ≥ 18 years. [+3]

Target lesions underwent or planned to revascularization. [+9]

Read more